Sonic Healthcare Past Earnings Performance
Past criteria checks 3/6
Sonic Healthcare's earnings have been declining at an average annual rate of -7.6%, while the Healthcare industry saw earnings declining at 19% annually. Revenues have been growing at an average rate of 4.5% per year. Sonic Healthcare's return on equity is 7%, and it has net margins of 5.8%.
Key information
-7.63%
Earnings growth rate
-7.59%
EPS growth rate
| Healthcare Industry Growth | 2.43% |
| Revenue growth rate | 4.55% |
| Return on equity | 6.97% |
| Net Margin | 5.85% |
| Next Earnings Update | 21 Aug 2025 |
Recent past performance updates
Recent updates
Subdued Growth No Barrier To Sonic Healthcare Limited's (ASX:SHL) Price
Jun 21
Estimating The Fair Value Of Sonic Healthcare Limited (ASX:SHL)
May 21Does Sonic Healthcare (ASX:SHL) Have A Healthy Balance Sheet?
Apr 01Sonic Healthcare (ASX:SHL) Will Want To Turn Around Its Return Trends
Mar 15Sonic Healthcare (ASX:SHL) Will Pay A Dividend Of A$0.44
Feb 25Analysts Are Updating Their Sonic Healthcare Limited (ASX:SHL) Estimates After Its Half-Year Results
Feb 21
Medical Leadership Model And NHS Contracts Will Improve Future Service Quality
Strategic acquisitions and partnerships are set to drive growth and profitability through expanded market presence and operational synergies.Sonic Healthcare Limited's (ASX:SHL) Popularity With Investors Is Under Threat From Overpricing
Nov 28Sonic Healthcare Limited's (ASX:SHL) Intrinsic Value Is Potentially 93% Above Its Share Price
Jul 27Revenue & Expenses Breakdown
How Sonic Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 24 | 9,330 | 545 | 259 | 0 |
| 30 Sep 24 | 9,149 | 528 | 254 | 0 |
| 30 Jun 24 | 8,967 | 511 | 250 | 0 |
| 31 Mar 24 | 8,680 | 508 | 241 | 0 |
| 31 Dec 23 | 8,392 | 505 | 232 | 0 |
| 30 Sep 23 | 8,281 | 595 | 225 | 0 |
| 30 Jun 23 | 8,169 | 685 | 217 | 0 |
| 31 Mar 23 | 8,417 | 850 | 215 | 0 |
| 31 Dec 22 | 8,666 | 1,015 | 213 | 0 |
| 30 Sep 22 | 9,003 | 1,238 | 210 | 0 |
| 30 Jun 22 | 9,340 | 1,461 | 206 | 0 |
| 31 Mar 22 | 9,209 | 1,463 | 231 | 0 |
| 31 Dec 21 | 9,078 | 1,465 | 255 | 0 |
| 30 Sep 21 | 8,916 | 1,390 | 251 | 0 |
| 30 Jun 21 | 8,754 | 1,315 | 248 | 0 |
| 31 Mar 21 | 8,339 | 1,133 | 240 | 0 |
| 31 Dec 20 | 7,923 | 951 | 233 | 0 |
| 30 Sep 20 | 7,378 | 739 | 231 | 0 |
| 30 Jun 20 | 6,832 | 528 | 229 | 0 |
| 31 Mar 20 | 6,703 | 554 | 289 | 0 |
| 31 Dec 19 | 6,573 | 581 | 350 | 0 |
| 30 Sep 19 | 6,353 | 565 | 430 | 0 |
| 30 Jun 19 | 6,134 | 550 | 510 | 0 |
| 31 Mar 19 | 5,952 | 510 | 500 | 0 |
| 31 Dec 18 | 5,770 | 470 | 489 | 0 |
| 30 Sep 18 | 5,655 | 473 | 481 | 0 |
| 30 Jun 18 | 5,541 | 476 | 472 | 0 |
| 31 Mar 18 | 5,430 | 468 | 466 | 0 |
| 31 Dec 17 | 5,319 | 460 | 460 | 0 |
| 30 Sep 17 | 5,220 | 444 | 454 | 0 |
| 30 Jun 17 | 5,122 | 428 | 449 | 0 |
| 31 Mar 17 | 5,081 | 444 | 450 | 0 |
| 31 Dec 16 | 5,040 | 460 | 450 | 0 |
| 30 Sep 16 | 5,029 | 456 | 447 | 0 |
| 30 Jun 16 | 5,018 | 451 | 444 | 0 |
| 31 Mar 16 | 4,829 | 406 | 425 | 0 |
| 31 Dec 15 | 4,639 | 362 | 407 | 0 |
| 30 Sep 15 | 4,420 | 355 | 389 | 0 |
| 30 Jun 15 | 4,201 | 348 | 372 | 0 |
| 31 Mar 15 | 4,115 | 365 | 361 | 0 |
| 31 Dec 14 | 4,029 | 382 | 350 | 0 |
| 30 Sep 14 | 3,971 | 383 | 341 | 0 |
Quality Earnings: SHL has high quality earnings.
Growing Profit Margin: SHL's current net profit margins (5.8%) are lower than last year (6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SHL's earnings have declined by 7.6% per year over the past 5 years.
Accelerating Growth: SHL's earnings growth over the past year (8%) exceeds its 5-year average (-7.6% per year).
Earnings vs Industry: SHL earnings growth over the past year (8%) exceeded the Healthcare industry -33.6%.
Return on Equity
High ROE: SHL's Return on Equity (7%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/07 08:54 |
| End of Day Share Price | 2025/07/07 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sonic Healthcare Limited is covered by 31 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Dennis Hulme | APP Securities Pty Ltd. |
| Saul Hadassin | Barrenjoey Markets Pty Limited |
| Benjamin Brayshaw | Barrenjoey Markets Pty Limited |